Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

Go back to Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
(NASDAQ: LEXX) Delayed: 10.92 -0.35 (3.11%)
Previous Close $11.27    52 Week High
Open $11.38    52 Week Low
Day High $11.53    P/E N/A 
Day Low $10.80    EPS
Volume 8,919       

(NASDAQ: LEXXW) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High
Open $0.00    52 Week Low
Day High $0.00    P/E N/A 
Day Low $0.00    EPS
Volume 125,187